AV
Artiman Ventures
Venture CapitalActiveArtiman is an early-stage Silicon Valley-based venture fund.
93
Investments
10
Exits
$1.5B
AUM
10.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Artiman Ventures.
Investment Thesis & Strategy
Artiman Ventures invests in early-stage fintech and venture capital companies, leveraging its Silicon Valley presence to identify promising opportunities.
Investment Activity
Deals per year over the last 9 years
1
20112
20121
20132
20142
20150
20163
20170
20181
2019Portfolio Companies
Selected investments from their portfolio of 93 companies
N
Nuvia
Other · Series A, 2019
N
Nuro
Robotics · Series A, 2017
A
Axiom
Enterprise · Series A, 2017
A
Aira
Healthcare · Series A, 2017
I
Innovaccer
Healthcare · Series A, 2015
S
SiFive
Other · Series B, 2015
K
Karius
Biotech · Series A, 2014
I
Inscripta
Biotech · Series A, 2014
V
Vlocity
SaaS · Series A, 2013
B
Bloomreach
SaaS · Series A, 2012
N
Netskope
Cybersecurity · Series A, 2012
S
Shape Security
Cybersecurity · Series A, 2011
Notable Exits
CompanyTypeYearValue / Acquirer
HydraFacialIPO2021$1.1B
Threshold PharmaceuticalsAcquisition2017$270M
Corvus PharmaceuticalsIPO2016—
AvingerIPO2015—
NateraIPO2015—
SequantaAcquisition2015$300M
NevroIPO2014—
Calithera BiosciencesIPO2014—
Proteon TherapeuticsIPO2014—
Portola PharmaceuticalsIPO2013—
Frequently Asked Questions
Artiman Ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Bronze Investments
East Palo Alto, United States · 8 deals
Step5 Venture Partners
East Palo Alto, United States · 1 deals
Bessemer Venture Partners
Redwood City, United States · 971 deals
Threshold
Menlo Park, United States · 841 deals
Lightspeed Venture Partners
Menlo Park, United States · 839 deals
Index Ventures
San Francisco, United States · 827 deals